The h1n1 vaccine global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
H1N1 Vaccine Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The h1n1 vaccine market size has grown strongly in recent years. It will grow from $3.16 billion in 2023 to $3.37 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to previous influenza outbreaks, global health security concerns, vaccine development and approval processes, global vaccination campaigns, public health education initiatives, government funding and subsidies, pharmaceutical industry agility.
The h1n1 vaccine market size is expected to see strong growth in the next few years. It will grow to $4.46 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to research on broad-spectrum vaccines, global vaccine equity initiatives, public health resilience building, global health governance strengthening, integration of h1n1 vaccination with routine immunization. Major trends in the forecast period include global pandemic preparedness, influenza vaccination programs, vaccine development advances, cross-protection research, global health initiatives, technological improvements in vaccine manufacturing, production capacity expansion, data monitoring and surveillance.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/h1n1-vaccine-global-market-report
Scope Of H1N1 Vaccine Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
H1N1 Vaccine Market Overview
Market Drivers –
The increase in expenditure for research and development activities in the field of immunology and vaccine is expected to propel the growth of the H1N1 vaccine market going forward. Immunology and vaccines are used to prevent infections and help in producing antibodies to fight infections. Immunology is a crucial area of research in the medical and biological sciences that focuses on understanding the immune system. The H1N1 vaccine is a preparation used to boost antibody production, which provides immunity against a variety of diseases. For instance, according to an article by the kENUP Foundation, a Europe-based non-profit supporting research-based innovation in health industries, in January 2021, governments spent at least $94.11 billion (€93 billion) on the development of vaccines and treatments since the start of the pandemic worldwide. The public sector committed 95% of the total spending, or $87.54 billion (€86.5 billion), in just 11 months to the development of vaccinations. Therefore, increasing expenditure for research and development activities in the field of immunology and vaccines is driving the growth of the H1N1 vaccine market.
Market Trends –
Strategic collaborations between companies is a key trend that is gaining popularity in the H1N1 (swine flu) vaccination market. Companies in the H1N1 (swine flu) Vaccination market are focusing on strategic collaborations to expand their market share. For instance, in August 2022, A significant, a pharmaceutical company and Open Orphan affiliate hVIVO have agreed to an agreement for $123 million to create a brand-new batch of H1N1 influenza challenge virus. This has stimulated the growth potential of both companies in the industry.
The h1n1 vaccine market covered in this report is segmented –
1) By Product Type: Inactivated Vaccine, Live Attenuated Vaccine
2) By Route Of Administration: Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination
3) By End Users: Hospitals, Clinics, Research and Diagnostic Laboratories, Other End Users
Get an inside scoop of the h1n1 vaccine market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=7881&type=smp
Regional Insights –
North America was the largest region in the H1N1 vaccine market in 2023. The regions covered in the h1n1 vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the h1n1 vaccine market report are Sanofi SA, Novartis AG, GlaxoSmithKline plc, CSL Limited, AstraZeneca Inc., Zydus Lifesciences Limited, Merck and Co.Inc., Novavax Inc., Baxter Laboratories Inc., Panacea Biotec Ltd., Sinovac Biotech Ltd., Green Cross Corp., Abbott Laboratories, Pfizer Inc., Mitsubishi Tanabe Pharma Corporation, Seqirus Ltd., Cipla Inc., Protein Sciences Corporation, Hualan Biological Engineering Inc., Changsheng Bio-Technology Co. Ltd., Takeda Pharmaceutical Ltd., Bharat Biotech International Limited, Serum Institute of India Pvt. Ltd., Bio Farma Group, PT Kalbe Farma Tbk, Daiichi Sankyo Chemical Pharma Co. Ltd., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Moderna Inc., CureVac NV, BioNTech SE, Inovio Pharmaceuticals Inc., Vaxart Inc., Altimmune Inc., Dynavax Technologies Corporation, VBI Vaccines Inc., GeoVax Labs Inc.
Table of Contents
1. Executive Summary
2. H1N1 Vaccine Market Report Structure
3. H1N1 Vaccine Market Trends And Strategies
4. H1N1 Vaccine Market – Macro Economic Scenario
5. H1N1 Vaccine Market Size And Growth
…..
27. H1N1 Vaccine Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The industrial protective footwear global market report 2024 from The Business Research Company provides comprehensive…
The foot and mouth disease vaccine global market report 2024 from The Business Research Company…
Market Size - The industrial burner market size has grown strongly in recent years. It…
Market Size - The industrial air chiller market size has grown strongly in recent years.…
Market Size - The incident and emergency management market size has grown rapidly in recent…
Market Size - The implantable heart pacemaker market size has grown steadily in recent years.…